Med-IQ

Know when it’s urgent. Early distinction between urgent and routine referrals helps reduce patient anxiety and supports smarter, more confident management decisions from the start.

Earn CME: https://clinical.med-iq.com/activity/navigating-a-new-diagnosis-of-benign-brain-tumor?utm_source=fb&utm_medium=social&utm_campaign=dk106-neuro-ch-fb

Developed in collaboration with Duke Health

LDLC management is changing, especially for high-risk primary prevention patients. Learn about the latest guidance for LDL-C lowering and new and emerging PCSK9 therapies (including novel oral options).
This complimentary, 30minute CME activity provides a concise, evidence-based update on treatment strategies for high-risk ASCVD patients, complete with faculty insights and real-world cases.
Earn 0.5 CME credit and stay ahead of what’s coming next in lipid management.
Join the activity: https://clinical.med-iq.com/activity/ldl-c-management-in-high-risk-ascvd-current-treatment-options-and-the-evolving-role-of-pcsk9-inhibitors?utm_source=fb&utm_medium=social&utm_campaign=me128-fb

Today, we recognize Juneteenth, a day marking the end of slavery in the United States and an opportunity to reflect on the ongoing pursuit of equity.

At Med-IQ, we are committed to supporting clinicians with education that helps address disparities, improve access, and foster trust with the patients they serve. This Juneteenth, we reaffirm our commitment to education that empowers better outcomes for every patient, everywhere.

Last chance to join our Project ECHO® sessions! Don't miss this opportunity to gain strategic insights from both an interprofessional expert team as well as community peers to help support the integration of BCMA-directed BsAbs into community practice and address access barriers to BCMA-directed therapies for patients.
https://bostonu.zoom.us/meeting/register/mzNr4sclQjKYCsu_YVwSug